[Change of serum endogenous digitalis-like substance undergoing cardiopulmonary bypass]

Tong Luo1, Jun Rui, Xin-Jian Li

  • 1Department of Thoracic and Cardiovascular Surgery, Third People's Hospital of Chengdu, Chengdu 610031, China.

Insights

Heart failure and cardiopulmonary bypass (CPB) increase endogenous digitalis-like substance (EDLS) levels. Plasma EDLS peaks 2-6 hours post-CPB, potentially improving cardiac function in heart disease patients.

Area of Science:

  • Cardiology
  • Biochemistry
  • Critical Care Medicine

Context:

  • Endogenous digitalis-like substance (EDLS) plays a role in cardiac function.
  • Heart failure and cardiopulmonary bypass (CPB) are significant clinical stressors.
  • Understanding EDLS dynamics is crucial for managing cardiac patients.

Purpose:

  • To investigate plasma concentrations of EDLS before and after CPB.
  • To assess the cardiac effects of EDLS in patients with heart disease.

Summary:

  • Plasma EDLS levels were significantly higher in NYHA IV patients pre-CPB.
  • CPB induced a release of EDLS, peaking 2-6 hours post-operation.
  • Higher EDLS concentrations correlated with NYHA IV status but not with inotropic support or blood pressure.

Impact:

  • EDLS release is triggered by heart failure and CPB.
  • CPB significantly elevates plasma EDLS concentrations in the early post-operative period.
  • Elevated EDLS may be associated with improved cardiac function in patients with heart conditions.
Abstract

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...